● Latest
Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease. Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator’s Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002) Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Sign In Register Free
All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Infectious Disease Men's Health Mental Health / Psychiatry Neurology Oncology Rare Diseases Respiratory / COPD / Asthma Rheumatology
● Clinical Trial

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

Researchers are looking for new ways to treat people with extensive-stage small cell lung cancer (SCLC) that has relapsed or is refractory. Gocatamig is a new type of…

clinicaltrialsgov 🕐 3 min read 25 Mar 2026
Read Full Article →
1
2
3
4
Latest Guidelines
View all →

Guidelines will appear here as they are published. Add your first guideline.

Clinical Trials
View all →
Clinical News
View all →
📰
Why are resident doctors striking and how much are they paid?
25 Mar 2026
📰
Hello world!
25 Mar 2026
📰
Doctors announce six-day strike in England as talks break down
25 Mar 2026
📰
Health devolution in Greater Manchester and South Yorkshire
NHS England 25 Mar 2026

Join 10,000+ UK Clinicians

Get weekly clinical updates — guidelines, trials, MHRA alerts — delivered to your inbox. Free for verified HCPs.

By registering you confirm you are a healthcare professional. No spam. Unsubscribe anytime.